Literature DB >> 31813069

Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Padacherri Vethil Jishnu1, Pradyumna Jayaram1, Vaibhav Shukla1, Vinay Koshy Varghese1, Deeksha Pandey2, Krishna Sharan3, Sanjiban Chakrabarty1, Kapaettu Satyamoorthy1, Shama Prasada Kabekkodu4.   

Abstract

Deregulated miR-379/miR-656 cluster expression is considered as important for carcinogenesis and can be used as a potential prognostic marker. Hence, the meta-analysis was conducted to test the utility of miR-379/miR-656 cluster as a prognostic marker in various cancers. A literature search was performed using Web of Science, PubMed and Cochrane Library to obtain relevant studies and were subjected to various subgroup and bioinformatics analyses. Selected twenty-three studies contained 13 cancer types comprising of 3294 patients from 7 nations. Univariate and multivariate data showed an association of high expression of miRNAs with the poor prognosis of cancer patients (p < 0.001). The subgroup analysis showed that lung cancer, breast cancer and papillary renal cell carcinoma (p < 0.001) have a negative association with the survival of patients. Our study is the first meta-analysis showing the association of miR-379/miR-656 cluster expression and overall survival, suggesting its potential as a prognostic indicator in multiple cancers.

Entities:  

Keywords:  Cancer; Meta-analysis; Prognostic marker; microRNA cluster; microRNA drug target

Year:  2019        PMID: 31813069     DOI: 10.1007/s10585-019-10013-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  82 in total

1.  Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.

Authors:  Ji Liu; Jian Jiang; Xiaobo Hui; Weijie Wang; Dazhao Fang; Lianshu Ding
Journal:  Cell Physiol Biochem       Date:  2018-08-10

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 3.  Aberrant regulation and function of microRNAs in cancer.

Authors:  Brian D Adams; Andrea L Kasinski; Frank J Slack
Journal:  Curr Biol       Date:  2014-08-18       Impact factor: 10.834

4.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.

Authors:  Lin Zhang; Stefano Volinia; Tomas Bonome; George Adrian Calin; Joel Greshock; Nuo Yang; Chang-Gong Liu; Antonis Giannakakis; Pangiotis Alexiou; Kosei Hasegawa; Cameron N Johnstone; Molly S Megraw; Sarah Adams; Heini Lassus; Jia Huang; Sippy Kaur; Shun Liang; Praveen Sethupathy; Arto Leminen; Victor A Simossis; Raphael Sandaltzopoulos; Yoshio Naomoto; Dionyssios Katsaros; Phyllis A Gimotty; Angela DeMichele; Qihong Huang; Ralf Bützow; Anil K Rustgi; Barbara L Weber; Michael J Birrer; Artemis G Hatzigeorgiou; Carlo M Croce; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

5.  Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals.

Authors:  Evgeny A Glazov; Sean McWilliam; Wesley C Barris; Brian P Dalrymple
Journal:  Mol Biol Evol       Date:  2008-02-14       Impact factor: 16.240

6.  miRmine: a database of human miRNA expression profiles.

Authors:  Bharat Panwar; Gilbert S Omenn; Yuanfang Guan
Journal:  Bioinformatics       Date:  2017-05-15       Impact factor: 6.937

7.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Authors:  Liron Zehavi; Roi Avraham; Aviv Barzilai; Dalia Bar-Ilan; Roy Navon; Yechezkel Sidi; Dror Avni; Raya Leibowitz-Amit
Journal:  Mol Cancer       Date:  2012-07-02       Impact factor: 27.401

8.  MicroRNA-376b promotes breast cancer metastasis by targeting Hoxd10 directly.

Authors:  Ning An; Xinmei Luo; Ming Zhang; Ruilian Yu
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

9.  Introduction, comparison, and validation of Meta-Essentials: A free and simple tool for meta-analysis.

Authors:  Robert Suurmond; Henk van Rhee; Tony Hak
Journal:  Res Synth Methods       Date:  2017-09-29       Impact factor: 5.273

10.  The evolution of the DLK1-DIO3 imprinted domain in mammals.

Authors:  Carol A Edwards; Andrew J Mungall; Lucy Matthews; Edward Ryder; Dionne J Gray; Andrew J Pask; Geoffrey Shaw; Jennifer A M Graves; Jane Rogers; Ian Dunham; Marilyn B Renfree; Anne C Ferguson-Smith
Journal:  PLoS Biol       Date:  2008-06-03       Impact factor: 8.029

View more
  5 in total

1.  CircSOX9 acts as a molecular sponge of miR-485-3p to promote the progression of nasopharyngeal carcinoma.

Authors:  Yanbo Sun; Yun Liu; Zhihui Du; Liangqiang Zhou; Qingguo Chen; Hanqi Chu
Journal:  Aging (Albany NY)       Date:  2022-06-14       Impact factor: 5.955

Review 2.  Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts.

Authors:  Li-Jie Li; Wei-Min Chang; Michael Hsiao
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

3.  Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.

Authors:  Isha Kapoor; Juraj Bodo; Brian T Hill; Alexandru Almasan
Journal:  Cell Death Dis       Date:  2021-11-08       Impact factor: 8.469

Review 4.  Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.

Authors:  Lilla Krokker; Attila Patócs; Henriett Butz
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

5.  miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence.

Authors:  Diane Frankel; Valérie Delecourt; Elva-María Novoa-Del-Toro; Jérôme D Robin; Coraline Airault; Catherine Bartoli; Aurélie Carabalona; Sophie Perrin; Kilian Mazaleyrat; Annachiara De Sandre-Giovannoli; Frederique Magdinier; Anaïs Baudot; Nicolas Lévy; Elise Kaspi; Patrice Roll
Journal:  iScience       Date:  2022-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.